July 2018 Funding Opportunities and Announcements
|
|
Welcome to the inaugural "funding flash" from the George Washington University (GW) Cancer Center. Questions? Contact us at
cancercenter@gwu.edu. Interested in subscribing to future updates? Click the button below:
|
|
Hirshberg Foundation for Pancreatic Cancer Research
|
Provides start-up funding for basic scientists and clinicians who intend to test innovative ideas for improving diagnosis and to develop new treatment modalitites for pancreatic cancer and who seek to impact the understanding of pancreatic cancer cell biology, biochemistry, physiology, morphology and response to therapy.
Deadline:
August 15, 2018
Amount/Project Period:
$40,000 over 1 year with opportunity for 1 year renewal
Eligibility:
Open to investigators at all levels
Reviewers:
Peer review and priority scores assigned by the Seed Grant Advisory Board of the Foundation, internal and external reviewers are recruited by the Foundation, however, recommendations for or exclusions of potential reviewers by the applicant are also considered.
|
|
Elsa U. Pardee Foundation Research Grants Program
|
Supports research directed toward identifying new treatments or cures for cancer.
Deadline:
August 31, 2018
Amount and Project Period:
Varies
Eligibility:
Open to investigators at all levels, though the Foundation particularly encourages grant applications for new cancer researchers, or new cancer approaches by established cancer researchers.
Reviewers:
Foundation is family-run
|
|
Leukemia & Lymphoma Society Translational Research Program
|
Seeks to foster collaboration between basic and clinical scientists with the intent of enhancing the transfer of basic research findings to clinical usefulness. Applications are sought proposing novel approaches to the prevention, diagnosis or treatment of hematological malignancies and related pre-malignant conditions.
Deadline:
August 31, 2018 (LOI)
Amount and Project Period:
$600,000 over 3 years
Eligibility
: Open to investigators at all levels.
Reviewers:
Medical and scientific affairs committee
|
|
Leukemia & Lymphoma Society Snowdome Foundation Translational Research Program for the Treatment of Blood Cancer
|
|
Seeks to foster collaboration between basic and clinical scientists with the intent of enhancing the transfer of basic research findings to clinical usefulness. Applications are sought proposing novel approaches to the prevention, diagnosis or treatment of hematological malignancies and related pre-malignant conditions.
Deadline:
August 31, 2018 (LOI)
Amount and Project Period:
$600,000 over 3 years
Eligibility
: Open to investigators at all levels, PI or a Co-PI must be from Australia
Reviewers:
Medical and scientific affairs committee
|
|
Leukemia & Lymphoma Society Pediatric Blood Cancer Research Iniative
|
|
Seeks to advance breakthroughs for the treatment of pediatric blood cancers.
Deadline:
August 31, 2018 (LOI)
Amount and Project Period:
$600,000 over 3 years
Eligibility
: Open to investigators at all levels.
Reviewers:
Medical and scientific affairs committee
|
|
Lymphoma Research Foundation Clinical Investigator Career Development Award
|
Designed to support physician investigators at the level of advanced fellow or junior faculty member who will contribute to the development of new lymphoma therapies and diagnostic tools.
Deadline:
September 6, 2018
Amount and Project Period:
$225,000 over 3 years
Eligibility:
Applicants must be licensed physicians and must be an advanced fellow or junior faculty member with at least 2 years of fellowship or postdoctoral training and no greater than 5 years of experience beyond completion of fellowship or postdoctoral training. Recipient is not permitted to hold any other career development award during period of LRF grant.
Reviewers:
Scientific advisory board
|
|
Lymphoma Research Foundation Postdoctoral Fellowships
|
Designed to support investigators at the level of advanced fellow or postdoctoral researcher in laboratory or clinic based research with results and conclusions that must be clearly relevant to the treatment, diagnosis or prevention of Hodgkin and/or non-Hodgkin lymphoma, including chronic lymphocytic leukemia.
Deadline:
September 6, 2018
Amount and Project Period:
$105,000 over 2 years
Eligibility:
Applicants must hold an MD, PhD, or equivalent degree. MD Applicants must have completed at least two years (24 months) of their fellowship work at the start of the award period (March 1, 2019). All applicants should not have completed more than five years (60 months) of their fellowship or postdoctoral work at the start of their award period. Applicants may not hold another competitively applied for fellowship and/or a grant that primarily supports Principal Investigator (PI) salary during the period of the LRF Grant.
Reviewers:
Scientific advisory board
|
|
Gilead Research Scholars in Hematology/Oncology Program
|
The program is designed to support innovative translational research projects in hematology/oncology, with a focus on hematologic malignancies that can be either based around a clinical trial with strong correlative science or laboratory investigation.
Deadline:
September 7, 2018
Amount and Project Period:
$130,000 over 2 years
Eligibility:
Award is intended for junior faculty. Investigator must be within 5 years of initial faculty appointment and must be a citizen or permanent resident of Canada or the United States or hold a temporary nonimmigrant visa.
Reviewers:
Applications will be reviewed by a
scientific review committee
, comprised of internationally-recognized experts in basic and clinical research in the field of hematology/oncology.
|
|
Union for International Cancer Control Yamagiwa-Yoshida Memorial International Study Grants
|
Enables individuals from any country to carry out cancer research projects abroad and including the opportunity to receive further training in research methods or techniques.
Deadline:
September 15, 2018
Amount and Project Period:
$10,000 over 3 months
Eligibility:
Must have received PhD or equivalent degree at least 2 years prior to the application closing date.
Reviewers:
Independent scientific review board
|
|
ASCO Conquer Cancer Foundation Career Development Award
|
Provides research funding to clinical investigators, who have received their initial faculty appointment, as they work to establish an independent clinical cancer research program. This research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects.
Deadline:
September 25, 2018
Amount and Project Period:
$200,000 over 3 years
Eligibility:
Must be in the first to third year of a full-time primary faculty appointment and be an ASCO member. Applicants should not have any current career development awards and have not been a PI on any large project grants.
Reviewers:
Scientific review committee
|
|
|
|
|
|
|
